• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者对临床试验中所提供信息的认知。

Patients' perceptions of information provided in clinical trials.

作者信息

Ferguson P R

机构信息

Department of Law, University of Dundee, Dundee, UK.

出版信息

J Med Ethics. 2002 Feb;28(1):45-8. doi: 10.1136/jme.28.1.45.

DOI:10.1136/jme.28.1.45
PMID:11834760
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1733530/
Abstract

BACKGROUND

According to the Declaration of Helsinki, patients who take part in a clinical trial must be adequately informed about the trial's aims, methods, expected benefits, and potential risks. The declaration does not, however, elaborate on what "adequately informed" might amount to, in practice. Medical researchers and Local Research Ethics Committees attempt to ensure that the information which potential participants are given is pitched at an appropriate level, but few studies have considered whether the patients who take part in such trials feel they have been given adequate information, or whether they feel able to understand that information.

OBJECTIVES

To explore trial participants' views (i) on the amount of information provided, and (ii) of their own understanding of that information.

DESIGN

Structured interviews of patients participating in clinical trials for the treatment of chronic medical condition.

FINDINGS

Patients generally felt they were given an appropriate amount of information, and that they were able to understand all or most of it. They felt they were given adequate time to ask questions before agreeing to take part. In comparison with treatment given out with the research setting, patients generally felt they received more information when participating in a clinical trial.

CONCLUSIONS

Researchers sometimes complain that patients are given too much information during clinical trials, and have limited understanding of that information. The present study shows that this perception is not necessarily shared by patients. More research is needed in this area, particularly to gauge whether patient understanding is indeed accurate.

摘要

背景

根据《赫尔辛基宣言》,参与临床试验的患者必须充分了解试验的目的、方法、预期益处和潜在风险。然而,该宣言并未详细说明在实际操作中“充分了解”具体意味着什么。医学研究人员和地方研究伦理委员会试图确保向潜在参与者提供的信息水平适当,但很少有研究考虑参与此类试验的患者是否觉得自己得到了充分的信息,或者他们是否觉得自己能够理解这些信息。

目的

探讨试验参与者对(i)所提供信息的数量,以及(ii)他们对这些信息的自身理解的看法。

设计

对参与慢性疾病治疗临床试验的患者进行结构化访谈。

研究结果

患者普遍认为他们得到了适量的信息,并且能够理解全部或大部分信息。他们觉得在同意参与之前有足够的时间提问。与在研究环境之外接受的治疗相比,患者普遍觉得参与临床试验时获得了更多信息。

结论

研究人员有时抱怨在临床试验期间给患者提供了过多信息,且患者对这些信息的理解有限。本研究表明,患者不一定有同样的看法。该领域需要更多研究,特别是要评估患者的理解是否确实准确。

相似文献

1
Patients' perceptions of information provided in clinical trials.患者对临床试验中所提供信息的认知。
J Med Ethics. 2002 Feb;28(1):45-8. doi: 10.1136/jme.28.1.45.
2
Informed consent: study of quality of information given to participants in a clinical trial.知情同意:关于向临床试验参与者提供的信息质量的研究。
BMJ. 1991 Sep 14;303(6803):610-3. doi: 10.1136/bmj.303.6803.610.
3
Information giving in clinical trials: the views of medical researchers.临床试验中的信息披露:医学研究人员的观点。
Bioethics. 2003 Feb;17(1):101-11. doi: 10.1111/1467-8519.00324.
4
Study of cohort-specific consent and patient control in phase I cancer trials.I期癌症试验中特定队列同意和患者控制的研究。
J Clin Oncol. 1998 Jul;16(7):2305-12. doi: 10.1200/JCO.1998.16.7.2305.
5
American Society of Clinical Oncology policy statement: oversight of clinical research.美国临床肿瘤学会政策声明:临床研究监督
J Clin Oncol. 2003 Jun 15;21(12):2377-86. doi: 10.1200/JCO.2003.04.026. Epub 2003 Apr 29.
6
Informed consent in an antiretroviral trial in Nigeria.尼日利亚一项抗逆转录病毒试验中的知情同意。
Indian J Med Ethics. 2007 Jan-Mar;4(1):26-30. doi: 10.20529/IJME.2007.009.
7
How to do it. Get patients' consent to enter clinical trials.如何去做。获得患者参加临床试验的同意。
BMJ. 1995 Sep 16;311(7007):734-7. doi: 10.1136/bmj.311.7007.734.
8
A survey of study participants' understanding of informed consent to participate in a randomised controlled trial of acupuncture.一项关于研究参与者对参与针灸随机对照试验的知情同意理解情况的调查。
BMC Complement Altern Med. 2016 Jan 12;16:10. doi: 10.1186/s12906-015-0975-y.
9
"Tell me what you suggest, and let's do that, doctor": Patient deliberation time during informal decision-making in clinical trials.“告诉我你的建议,我们就这么办,医生”:临床试验中非正式决策过程中的患者决策时间。
PLoS One. 2019 Jan 29;14(1):e0211338. doi: 10.1371/journal.pone.0211338. eCollection 2019.
10
Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.治疗性研究对知情同意及临床试验伦理的影响:肿瘤医学视角
J Clin Oncol. 1999 May;17(5):1601-17. doi: 10.1200/JCO.1999.17.5.1601.

引用本文的文献

1
What information and the extent of information to be provided in an informed assent/consent form of pediatric drug trials.儿科药物临床试验知情同意书/同意书中应提供哪些信息及提供信息的范围。
BMC Med Ethics. 2022 Nov 16;23(1):113. doi: 10.1186/s12910-022-00856-y.
2
Patient perceptions of the challenges of recruitment to a renal randomised trial registry: a pilot questionnaire-based study.患者对肾脏随机试验注册招募挑战的看法:一项基于问卷的初步研究。
Trials. 2021 Sep 6;22(1):597. doi: 10.1186/s13063-021-05526-9.
3
Informational needs for participation in bioequivalence studies: the perspectives of experienced volunteers.参与生物等效性研究的信息需求:有经验志愿者的观点。
Eur J Clin Pharmacol. 2019 Nov;75(11):1575-1582. doi: 10.1007/s00228-019-02738-6. Epub 2019 Aug 19.
4
"Tell me what you suggest, and let's do that, doctor": Patient deliberation time during informal decision-making in clinical trials.“告诉我你的建议,我们就这么办,医生”:临床试验中非正式决策过程中的患者决策时间。
PLoS One. 2019 Jan 29;14(1):e0211338. doi: 10.1371/journal.pone.0211338. eCollection 2019.
5
What information and the extent of information research participants need in informed consent forms: a multi-country survey.信息研究参与者在知情同意书中需要哪些信息以及信息的详细程度:一项多国调查。
BMC Med Ethics. 2018 Sep 15;19(1):79. doi: 10.1186/s12910-018-0318-x.
6
Informed consent in oncology clinical trials: A Brown University Oncology Research Group prospective cross-sectional pilot study.肿瘤学临床试验中的知情同意:布朗大学肿瘤学研究小组前瞻性横断面试点研究。
PLoS One. 2017 Feb 24;12(2):e0172957. doi: 10.1371/journal.pone.0172957. eCollection 2017.
7
[Informed consent process in clinical trials: Insights of researchers, patients and general practitioners].[临床试验中的知情同意过程:研究人员、患者和全科医生的见解]
Aten Primaria. 2016 Oct;48(8):518-526. doi: 10.1016/j.aprim.2015.10.008. Epub 2016 Jan 14.
8
A survey of study participants' understanding of informed consent to participate in a randomised controlled trial of acupuncture.一项关于研究参与者对参与针灸随机对照试验的知情同意理解情况的调查。
BMC Complement Altern Med. 2016 Jan 12;16:10. doi: 10.1186/s12906-015-0975-y.
9
Continuing review of ethics in clinical trials: a surveillance study in Iran.临床试验伦理的持续审查:伊朗的一项监测研究
J Med Ethics Hist Med. 2013 Sep 8;6:8. eCollection 2013.
10
Recruiting ethnic minority participants to a clinical trial: a qualitative study.招募少数民族参与者参与临床试验:一项定性研究。
BMJ Open. 2013 Apr 8;3(4). doi: 10.1136/bmjopen-2013-002750. Print 2013.

本文引用的文献

1
The problem of informed consent in emergency medicine research.急诊医学研究中的知情同意问题。
Emerg Med J. 2001 May;18(3):198-204. doi: 10.1136/emj.18.3.198.
2
The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals.从患者、公众和医疗保健专业人员角度看随机对照试验的伦理问题
BMJ. 1998 Oct 31;317(7167):1209-12. doi: 10.1136/bmj.317.7167.1209.
3
Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial.随机分配还是随机化分配?患者对参与随机对照试验的看法。
BMJ. 1998 Oct 31;317(7167):1177-80. doi: 10.1136/bmj.317.7167.1177.
4
Reactions of participants to the results of a randomised controlled trial: exploratory study.参与者对随机对照试验结果的反应:探索性研究。
BMJ. 1998 Jul 4;317(7150):21-6. doi: 10.1136/bmj.317.7150.21.
5
Local Research Ethics Committees can audit ethical standards in research.当地研究伦理委员会可以对研究中的伦理标准进行审核。
J Med Ethics. 1997 Dec;23(6):379-81. doi: 10.1136/jme.23.6.379.
6
Making sense of randomization; responses of parents of critically ill babies to random allocation of treatment in a clinical trial.理解随机分组;重症婴儿父母对临床试验中治疗随机分配的反应。
Soc Sci Med. 1997 Nov;45(9):1337-55. doi: 10.1016/s0277-9536(97)00063-4.
7
Offering patients entry in clinical trials: preliminary study of the views of prospective participants.让患者参与临床试验:对潜在参与者观点的初步研究。
J Med Ethics. 1996 Aug;22(4):227-31. doi: 10.1136/jme.22.4.227.
8
The adequacy of consent forms for informing patients entering oncological clinical trials.用于告知参与肿瘤学临床试验患者的知情同意书的充分性。
Ann Oncol. 1995 Nov;6(9):867-70. doi: 10.1093/oxfordjournals.annonc.a059352.
9
Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?描述临床肿瘤学研究方案的知情同意书大多数患者及其家属能读懂吗?
J Clin Oncol. 1994 Oct;12(10):2211-5. doi: 10.1200/JCO.1994.12.10.2211.
10
Readability of subject information leaflets for medical research.医学研究受试者信息手册的可读性
N Z Med J. 1994 Dec 14;107(991):509-10.